Home » Topics » Regulatory

Regulatory
RSS

3M submits Aldara sNDA for actinic keratosis

May 14, 2003

FDA approves revised labeling for Flonase

May 14, 2003

Adderall XR program in adolescents to extend marketing exclusivity

May 13, 2003

FDA approves new flexible dosing regimen for Lantus

May 13, 2003

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Effective use of transdermal buprenorphine in cancer and noncancer pain

May 9, 2003

Vioxx approved in Canada for use in rheumatoid arthritis

May 9, 2003

New Risperdal formulation launched

May 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...